4.5 Article

Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells

Journal

MOLECULAR CANCER RESEARCH
Volume 13, Issue 9, Pages 1283-1295

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-15-0075

Keywords

-

Funding

  1. Wilhelm-Sander-Stiftung [2011.083.1]
  2. DFG International Graduate School [1302 (TP T9 SH)]
  3. Robert-Bosch-Stiftung
  4. ICEPHA program of the University of Tubingen

Ask authors/readers for more resources

Ca2+-activated K+ channels, such as BK and IK channels, have been proposed to fulfill pivotal functions in neoplastic transformation, malignant progression, and brain infiltration of glioblastoma cells. Here, the ionizing radiation (IR) effect of IK K+ channel targeting was tested in human glioblastoma cells. IK channels were inhibited pharmacologically by TRAM-34 or genetically by knockdown, cells were irradiated with 6MVphotons and IK channel activity, Ca2+ signaling, cell cycling, residual doublestrand breaks, and clonogenic survival were determined. In addition, the radiosensitizing effect of TRAM-34 was analyzed in vivo in ectopic tumors. Moreover, The Cancer Genome Atlas (TCGA) was queried to expose the dependence of IK mRNA abundance on overall survival (OS) of patients with glioma. Results indicate that radiation increased the activity of IK channels, modified Ca2+ signaling, and induced a G(2)-M cell-cycle arrest. TRAM-34 decreased the IR-induced accumulation in G(2)-M arrest and increased the number of gamma H2AX foci post-IR, suggesting that TRAM-34 mediated an increase of residual DNA double-strand breaks. Mechanistically, IK knockdown abolished the TRAM-34 effects indicating the IK specificity of TRAM-34. Finally, TRAM-34 radiosensitized ectopic glioblastoma in vivo and high IK mRNA abundance associated with shorter patient OS in low-grade glioma and glioblastoma. (C) 2015 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

Volker Arndt, Daniela Doege, Stefan Froehling, Peter Albers, Hana Alguel, Ralf Bargou, Carsten Bokemeyer, Martin Bornhaeuser, Christian H. Brandts, Peter Brossart, Sara Yvonne Brucker, Tim H. Bruemmendorf, Hartmut Doehner, Norbert Gattermann, Michael Hallek, Volker Heinemann, Ulrich Keilholz, Thomas Kindler, Cornelia von Levetzow, Florian Lordick, Ulf Peter Neumann, Christoph Peters, Dirk Schadendorf, Stephan Stilgenbauer, Thomas Zander, Daniel Zips, Delia Braun, Thomas Seufferlein, Gerd Nettekoven, Michael Baumann

Summary: The capacities of German Comprehensive Cancer Centers (CCCs) in various aspects of oncology care were significantly affected during the first 2 years of the COVID-19 pandemic. Follow-up, psycho-oncologic care, and tumor surgery were particularly impacted, along with other areas of multidisciplinary oncological care. This study highlights the importance of developing strategies to prevent similar limitations in the future.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

Article Oncology

Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases

Laura Uder, Marcel Nachbar, Sarah Butzer, Jessica Boldt, Sabrina Baumeister, Michael Bitzer, Alfred Koenigsrainer, Thomas Seufferlein, Ruediger Hoffmann, Sergios Gatidis, Konstantin Nikolaou, Daniel Zips, Daniela Thorwarth, Cihan Gani, Simon Boeke

Summary: This study reported on the use of online magnetic resonance guided radiotherapy for liver metastases. The results showed high local control rates and improvements in patient reported outcome measures and quality of life. Further prospective trials are ongoing to define the patient population that will benefit most from this online adaptive workflow.

FRONTIERS IN ONCOLOGY (2023)

Article Oncology

Impact of endorectal filling on interobserver variability of MRI based rectal primary tumor delineation

Monica Lo Russo, Marcel Nachbar, Aisling Barry, Shree Bhide, Amy Chang, William Hall, Martijn Intven, Corrie Marijnen, Femke Peters, Bruce Minsky, Paul B. Romesser, Reith Sarkar, Alex Tan, Simon Boeke, Daniel Wegener, Sarah Butzer, Jessica Boldt, Sergios Gatidis, Konstantin Nikolaou, Daniela Thorwarth, Daniel Zips, Cihan Gani

Summary: This study investigated the impact of rectal ultrasound gel filling on interobserver variability in the delineation of primary rectal tumor volumes. The study found that rectal ultrasound gel filling can improve interobserver agreement and may be a useful tool for future dose escalation strategies.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Article Oncology

Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models

Siyer Roohani, Juergen Loskutov, Jens Heufelder, Felix Ehret, Lena Wedeken, Manuela Regenbrecht, Rica Sauer, Daniel Zips, Andrea Denker, Antonia M. Joussen, Christian R. A. Regenbrecht, David Kaul

Summary: A pilot study was conducted using patient-derived 3D cell cultures to investigate the effects of photon and proton radiation on different subtypes of localized high-grade soft tissue sarcoma (STS). The study found pronounced differences in radiosensitivity among different subtypes of STS, and showed that photon and proton radiation had similar dose-dependent cell-killing effectiveness in the 3D cell cultures.

BMC CANCER (2023)

Article Oncology

Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial

Rolf D. Issels, Stefan Boeck, Uwe Pelzer, Ulrich Mansmann, Pirus Ghadjar, Lars H. Lindner, Markus Albertsmeier, Martin K. Angele, Michael Schmidt, Yujun Xu, Marcus Bahra, Johann Pratschke, Michael Schoenberg, Wolfgang E. Thasler, Christoph Salat, Oliver J. Stoetzer, Wolfram T. Knoefel, Dirk Graf, Rudiger Wessalowski, Verena Keitel-Anselmino, Alfred Koenigsrainer, Michael Bitzer, Daniel Zips, Michael Bamberg, Rainer Fietkau, Oliver Ott, Maciej Kawecki, Lucian Wyrwicz, Piotr Rutkowski, Markus Rentsch, Juliana Ababei, Peter Reichardt, Marco Rigamonti, Bernhard Weber, Sultan Abdel-Rahman, Katharina Tschoep-Lechner, Karl-Walter Jauch, Christiane J. Bruns, Helmut Oettle, Michael von Bergwelt-Baildon, Volker Heinemann, Jens Werner

Summary: In this randomized controlled trial, the addition of cisplatin to gemcitabine with regional hyperthermia did not significantly improve disease-free survival in resected pancreatic ductal adenocarcinoma, but it showed a difference in post-recurrence survival and a trend for improved overall survival.

EUROPEAN JOURNAL OF CANCER (2023)

Article Oncology

Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: the PUMA trial

Sebastian Regnery, Chiara de Colle, Chukwuka Eze, Stefanie Corradini, Christian Thieke, Oliver Sedlaczek, Heinz-Peter Schlemmer, Julien Dinkel, Ferdinand Seith, Annette Kopp-Schneider, Clarissa Gillmann, C. Katharina Renkamp, Guillaume Landry, Daniela Thorwarth, Daniel Zips, Claus Belka, Oliver Jaekel, Juergen Debus, Juliane Hoerner-Rieber

Summary: This study aims to explore the clinical feasibility of MR-guided online adaptive radiotherapy for locally-advanced non-small-cell lung cancer (LA-NSCLC). The study will be conducted at three German university hospitals, with 30 patients receiving MR-guided online adaptive radiotherapy along with chemotherapy. The primary endpoints are successful completion of online adapted fractions and on-table time.

RADIATION ONCOLOGY (2023)

Article Oncology

Cardiac radioablation of incessant ventricular tachycardia in patients with terminal heart failure under permanent left ventricular assist device therapy-description of two cases

Felix Mehrhof, Paula Bergengruen, Jin-Hong Gerds-Li, Andrea Jahn, Anne Kathrin Kluge, Abdul Parwani, Daniel Zips, Leif-Hendrik Boldt, Felix Schoenrath

Summary: This study discussed the experience of two patients with incessant ventricular tachycardia (VT) under long-term left ventricular assist device (LVAD) therapy. Cardiac radioablation (cRA) with a single dose of 25 Gy was used as a last resort treatment option. Although rhythm conversion failed in both patients, one patient was stabilized and discharged before succumbing to a fatal bleeding complication, while the other patient required additional ablation and died 50 days later. Strategies for post-procedural generation of stabilized rhythm should be established for these patients.

STRAHLENTHERAPIE UND ONKOLOGIE (2023)

Article Oncology

Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma A case study

Paula Maria Bergengruen, Pablo Hernaiz Driever, Volker Budach, Daniel Zips, Arne Gruen

Summary: This case report presents a 6-year-old boy with DIPG who received a second course of re-irradiation as part of an individual multimodal approach. The second course of re-irradiation was well tolerated and resulted in a survival of 24 months after initial diagnosis.

STRAHLENTHERAPIE UND ONKOLOGIE (2023)

Article Oncology

What if: A retrospective reconstruction of resection cavity stereotactic radiosurgery to mimic neoadjuvant stereotactic radiosurgery

Gueliz Acker, Marcel Nachbar, Nina Soffried, Bohdan Bodnar, Anastasia Janas, Kiril Krantchev, Goda Kalinauskaite, Anne Kluge, David Shultz, Alfredo Conti, David Kaul, Daniel Zips, Peter Vajkoczy, Carolin Senger

Summary: Neoadjuvant stereotactic radiosurgery (NaSRS) is becoming increasingly important in the treatment of brain metastases. Our analysis showed that there was no significant difference in tumor volume pre- and postoperatively, and smaller tumors had a higher risk of volume increase. However, contouring resection cavities remains a challenge.

FRONTIERS IN ONCOLOGY (2023)

Article Oncology

Adaptive radiotherapy for breast cancer

C. De-Colle, A. Kirby, N. Russell, S. F. Shaitelman, A. Currey, E. Donovan, E. Hahn, K. Hang, C. N. Anandadas, F. Mahmood, E. L. Lorenzen, D. van den Bongard, M. L. Groot Koerkamp, A. C. Houweling, M. Nachbar, D. Thorwarth, D. Zips

Summary: Research in the field of local and locoregional breast cancer radiotherapy aims to optimize treatment outcomes and minimize treatment-related toxicities. Adaptive radiotherapy (ART) takes into account anatomical variations in the target area and organs at risk (OARs) during treatment, resulting in re-optimized treatment plans. This review examines the use of MR-guided and CT-guided ART in different clinical scenarios for breast cancer patients and discusses their advantages and challenges.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Article Oncology

Patterns of Failure in High-Grade Soft Tissue Sarcomas of the Extremities and Trunk Wall After Pre- or Postoperative Radiation Therapy

Siyer Roohani, Felix Ehret, Marta Kobus, Anne Floercken, Sven Maerdian, Daniel Rau, Silvan Wittenberg, Armin Jarosch, Robert Oellinger, Daniel Zips, David Kaul

Summary: The study examines the pattern of local recurrence in patients with high-grade soft tissue sarcomas who received pre-or postoperative radiotherapy. The majority of recurrences were found within the planned target volume, indicating that inadequate target volume definition may not be the primary cause of recurrence. Importance rating: 8/10.

ADVANCES IN RADIATION ONCOLOGY (2023)

Article Oncology

Treating oligodendroglioma - An analysis of a homogeneous 1p/19q-codeleted and isocitrate dehydrogenase-mutant patient cohort

Luisa Allwohn, Josy Wolfgang, Julia Onken, David Wasilewski, Siyer Roohani, Daniel Zips, Felix Ehret, David Kaul

Summary: This study analyzes the influence of various tumor and patient characteristics on survival outcomes in patients with oligodendrogliomas (ODG) who have the 1p/19q-codeletion and IDH mutation. The results show that extent of resection, radiotherapy, and chemotherapy are associated with improved progression-free survival (PFS) in WHO grade 2 ODG, while only radiochemotherapy contributes to decreased risk of progression in WHO grade 3 ODG.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Article Oncology

Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study

Haidara Almansour, Fritz Schick, Marcel Nachbar, Saif Afat, Victor Fritz, Daniela Thorwarth, Daniel Zips, Felix Bertram, Arndt-Christian Mueller, Konstantin Nikolaou, Ahmed E. Othman, Daniel Wegener

Summary: This study investigated the dynamics of lesion ADC in patients with prostate cancer undergoing MR-guided radiation therapy on a 1.5T MR-Linac. The results showed a significant increase in lesion ADC during radiotherapy, suggesting that lesion ADC can be used as a biomarker for evaluating treatment response. However, the absolute ADC values calculated by the algorithm of the MR-Linac manufacturer showed systematic deviations from values obtained on a diagnostic 3T MRI system.

RADIOLOGY AND ONCOLOGY (2023)

Article Oncology

Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system

Mirjam Renovanz, Sylvia C. Kurz, Johannes Rieger, Bianca Walter, Hannes Becker, Hanni Hille, Paula Bombach, David Rieger, Lucia Grosse, Lara Haeusser, Marco Skardelly, Daniel J. Merk, Frank Paulsen, Elgin Hoffmann, Cihan Gani, Manuela Neumann, Rudi Beschorner, Olaf Riess, Cristiana Roggia, Christopher Schroeder, Stephan Ossowski, Sorin Armeanu-Ebinger, Axel Gschwind, Saskia Biskup, Martin Schulze, Falko Fend, Stephan Singer, Lars Zender, Claudia Lengerke, Sara Yvonne Brucker, Tobias Engler, Andrea Forschner, Arnulf Stenzl, Oliver Kohlbacher, Sven Nahnsen, Gisela Gabernet, Sven Fillinger, Benjamin Bender, Ulrike Ernemann, Oeznur Oener, Janina Beha, Holly Sundberg Malek, Yvonne Moeller, Kristina Ruhm, Marcos Tatagiba, Jens Schittenhelm, Michael Bitzer, Nisar Malek, Daniel Zips, Ghazaleh Tabatabai

Summary: This study investigates the feasibility and clinical utility of molecular profiling and targeted therapy in patients with advanced tumors in the nervous system. The results show that 93.1% of patients can receive biomarker-guided therapy recommendations, with treatment initiated in 22.6% of cases and a progression-free survival ratio >1.3 observed in 31.3% of patients. These findings support the clinical efficacy of biomarker-guided therapies in neuro-oncology patients and have implications for future clinical trials and care.

NEURO-ONCOLOGY ADVANCES (2023)

Article Oncology

Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - Hypothesis generation on a multicentre cohort of the DKTK-ROG

Steffen Loeck, Annett Linge, Fabian Lohaus, Nadja Ebert, Volker Gudziol, Alexander Nowak, Ingeborg Tinhofer, Goda Kalinauskaite, Maja Guberina, Martin Stuschke, Panagiotis Balermpas, Jens von der Gruen, Anca-Ligia Grosu, Juergen Debus, Ute Ganswindt, Claus Belka, Jan C. Peeken, Stephanie E. Combs, Chiara De-Colle, Daniel Zips, Gustavo B. Baretton, Mechthild Krause, Michael Baumann

Summary: Prognostic biomarker signatures were developed for patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with primary radiochemotherapy. The study identified several clinical parameters and biomarkers associated with loco-regional tumor control and overall survival. Multiple biomarker signatures were defined and showed significant patient stratifications for the endpoints. Further validation is needed before potential application in an interventional trial.

RADIOTHERAPY AND ONCOLOGY (2022)

No Data Available